J9271 — Pembrolizumab 25 Mg/ml Intravenous Solution
$29,115
All-payer median here
$32,652
Cash / self-pay here
1
payer/plan-name variants
Median over current-blob negotiated rates (COALESCE of standard / median / min–max midpoint, $0.01–$5M sentinel guard). Payers are canonical-grouped where a mapping exists; unmapped regional-plan name variants may appear as separate rows.